We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Expeditors International
EXPD
$23.2B
| $705K | ﹤0.01% |
5,802
+2
| +0% | +$247 |
|
2127
BlackBerry
BB
$5.26B
| $702K | ﹤0.01% |
+254,240
| New | +$743K |
|
|
MCBC
2128
DELISTED
Macatawa Bank Corp
MCBC
| $702K | ﹤0.01% |
71,658
+26,281
| +58% | +$269K |
|
2129
Towne Bank
TOWN
$3.42B
| $700K | ﹤0.01% |
24,958
+14,658
| +142% | +$407K |
|
2130
NCR Atleos
NATL
$3.44B
| $700K | ﹤0.01% |
35,448
+20,948
| +144% | +$448K |
|
2131
Fidelity MSCI Communication Services Index ETF
FCOM
$1.78B
| $699K | ﹤0.01% |
14,100
-10,300
| -42% | -$488K |
|
2132
BioAtla
BCAB
$5.74M
| $699K | ﹤0.01% |
4,062
+645
| +19% | +$80.1K |
|
|
ZEUS
2133
DELISTED
Olympic Steel
ZEUS
| $697K | ﹤0.01% |
9,840
-13,550
| -58% | -$905K |
|
2134
SP Funds S&P 500 Sharia ETF
SPUS
$3.07B
| $697K | ﹤0.01% |
18,400
-8,100
| -31% | -$292K |
|
2135
Hagerty
HGTY
$1.39B
| $696K | ﹤0.01% |
76,119
+44,809
| +143% | +$375K |
|
2136
Kodak
KODK
$983M
| $692K | ﹤0.01% |
139,769
-63,809
| -31% | -$256K |
|
2137
Bentley Systems
BSY
$10.6B
| $690K | ﹤0.01% |
13,204
-11,896
| -47% | -$599K |
|
|
CSR
2138
Centerspace
CSR
$952M
| $689K | ﹤0.01% |
+12,059
| New | +$671K |
|
2139
Celanese
CE
$4.82B
| $688K | ﹤0.01% |
4,002
-10,498
| -72% | -$1.6M |
|
2140
Tyra Biosciences
TYRA
$1.58B
| $685K | ﹤0.01% |
+41,742
| New | +$685K |
|
2141
Pampa Energía
PAM
$4.41B
| $684K | ﹤0.01% |
15,846
-2,000
| -11% | -$89.1K |
|
2142
AMN Healthcare
AMN
$1.4B
| $682K | ﹤0.01% |
10,913
-4,380
| -29% | -$298K |
|
2143
Bridgewater Bancshares
BWB
$603M
| $680K | ﹤0.01% |
58,418
+6,329
| +12% | +$77.1K |
|
2144
PMV Pharmaceuticals
PMVP
$63.5M
| $680K | ﹤0.01% |
399,710
+121,009
| +43% | +$226K |
|
2145
Santander
BSBR
$43.5B
| $679K | ﹤0.01% |
+118,675
| New | +$697K |
|
|
JBIO
2146
Jade Biosciences
JBIO
$1.34B
| $678K | ﹤0.01% |
655
+376
| +135% | +$287K |
|
2147
Dave Inc
DAVE
$4.06B
| $677K | ﹤0.01% |
+18,222
| New | +$420K |
|
2148
Liquidity Services
LQDT
$1.32B
| $676K | ﹤0.01% |
36,342
-67,774
| -65% | -$1.18M |
|
2149
PLAYSTUDIOS Inc
MYPS
$90.1M
| $675K | ﹤0.01% |
242,771
+18,511
| +8% | +$43K |
|
2150
ASE Group
ASX
$82.2B
| $675K | ﹤0.01% |
61,400
| – | – |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.